Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 06, 2016 8:33 PM ET

Healthcare Equipment and Supplies

Company Overview of Sanovas, Inc.

Company Overview

Sanovas, Inc. provides medical devices for the treatment of lung cancer. It offers its solutions based on vas zeppelin clear vessel technology for drug therapy, physiologic metrics, micro biopsy, and immuno-therapy applications. The company also provides MicroCam, an OEM plug and play micro imaging platform for endoscopic device applications. Its MicroCam technology features proprietary software, electronics, sensors, and optics that provide autonomous imaging capability when integrated with medical device makers' existing portfolios. Sanovas was incorporated in 2010 and is based in San Rafael, California.

2597 Kerner Boulevard

San Rafael, CA 94901

United States

Founded in 2010





Key Executives for Sanovas, Inc.

Co-Founder, Chairman, Chief Executive Officer and President
Age: 44
Vice President of Capital Markets and Development
Vice President of Clinical Affairs and Education
Vice President of Research and Development
Vice President of Product Management
Compensation as of Fiscal Year 2015.

Sanovas, Inc. Key Developments

Sanovas, Inc. Receives FDA Clearance for Pulmovia

Sanovas, Inc. announced that the company has received FDA 510(k) Clearance to market its PulmoVia Working Channel. The PulmoVia is one of several essential tools in the platform of patented technologies Sanovas is developing to improve diagnostic and therapeutic interventions in the lung. Traditional Bronchoscopes incorporate small-diameter operating channels into large-diameter optical assemblies. This combination of devices has limited the size, quantity and capabilities of the tools the clinician can effectively pass through these small diameter operating channels to diagnose and treat the lungs. The large optical and steering components of Traditional Bronchoscopes compromise the available size left for the working channel, thus restricting the size of complementary endoscopic accessories, such as Biopsy forceps, that may be passed through them. These traditionally small channels also restrict flow, hampering attempts to irrigate and suction the lungs of critical care patients with heavy bronchial secretions and clots. The PulmoVia decouples the operating channel from the optical assembly to transform the current paradigm, thereby enabling the delivery of a large-diameter operating channel via a small-diameter optic. This advance can effectively double the amount of space within the operating channel, without increasing the geometric footprint of the device. This naturally maximizes the size, quantity and capabilities of the tools the clinician can use to diagnose and treat the lungs. The PulmoVia Working Channel was designed so that clinicians can utilize much larger instruments to obtain tissue samples, retrieve foreign bodies, and initiate therapies while keeping their critical care patients breathing easily. In addition, since PulmoVia is a single-patient-use, disposable device procedure costs are minimized while staff is freed from the burdens of reprocessing.

Sanovas, Inc. Presents at 2nd Annual Growth Capital Expo, Apr-13-2015

Sanovas, Inc. Presents at 2nd Annual Growth Capital Expo, Apr-13-2015 . Venue: Caesars Palace, Las Vegas, Nevada, United States.

Sanovas, Inc. Expands Management Team

Sanovas Inc. announced that it has appointed five experienced executives to its management team: Ray Gamini (Sun Microsystems, Cisco Systems), Vice President of Finance; Roy Morgan (Abbott Laboratories, NIPRO Diabetes Systems, Stryker), Director, Research & Development; Christian Haller (MPR Associates), Vice President, Business Development; Steve Budill (Merit Medical, Stryker), Vice President, Product Management; and, John Galasso (Abbott Laboratories, Ascend/Lucent Technologies), Manager, Mechanical Engineering.

Similar Private Companies By Industry

Company Name Region
IDEXX Distribution, Inc. United States
Newmatic Medical United States
Care Wise Medical Products Corporation United States
Wellstream Health Services, LLC United States
Zurlin Technologies, LLC United States

Recent Private Companies Transactions

Private Placement
September 1, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Sanovas, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at